AWT020 not checked

Anwita Biosciences

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 1 trial completes
Trials
2 active
2 in total
Targets
 

What this is

How it works
How it works isn't classified yet
How it’s given
“Participants receiving AWT020 once every two weeks or longer at designated dose levels”In the company’s words, NCT06092580 on ClinicalTrials.gov
Tested for
Advanced Cancer, Advanced Cancers (Solid Tumors)
Main trialPhase 1
“The aims of this clinical trial are (1) to assess the safety of AWT020 at different dose levels; (2) to determine the pharmacokinetics and pharmacodynamics of AWT020 in subjects with locally advanced or metastatic cancer who have failed standard therapy.”In the company’s words, NCT06092580 on ClinicalTrials.gov

Other drugs for Advanced Cancer

All 2438 drugs for Advanced Cancer

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials2

TrialPhaseCompletesWhat it tests
Phase 1Recruiting 30 Jun 2026 Phase 1 Study of AWT020 in Advanced Cancer
Phase 1Recruiting Jan 2029 A Study of AWT020 in Participants With Advanced Solid Tumors
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow AWT020

Following is part of Solo: you see every change to AWT020 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in